Clinical trials in ovarian cancer / Christine S. Walsh.
Material type: TextPublisher: New Brunswick, New Jersey : Rutgers University Press, [2017]Description: 1 online resourceContent type:- text
- computer
- online resource
- 9780813586489
- 0813586488
- 0813586496
- 9780813586496
- 9780813586472
- 081358647X
- Ovaries -- Cancer -- Treatment
- Clinical trials
- Ovarian Neoplasms -- therapy
- Clinical Trials, Phase III as Topic
- Ovaires -- Cancer -- Traitement
- Études cliniques
- Gynaecology & obstetrics
- HEALTH & FITNESS -- Diseases -- General
- MEDICAL -- Clinical Medicine
- MEDICAL -- Diseases
- MEDICAL -- Evidence-Based Medicine
- MEDICAL -- Internal Medicine
- Clinical trials
- Ovaries -- Cancer -- Treatment
- RC280.O8
- 2017 B-742
- WP 322
Item type | Current library | Call number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|
E-Book | De Gruyter | Available | ||||
E-Book | Directory of Open Access Books | Not For Loan | ||||
E-Book | JSTOR Open Access Books | Available |
Includes bibliographical references and index.
Early stage epithelial ovarian cancer -- Advanced stage epithelial ovarian cancer : adjuvant chemotherapy -- Advanced stage epithelial ovarian cancer : timing of surgery and interval cytoreduction -- Epithelial ovarian cancer : maintenance therapy -- Recurrent epithelial ovarian cancer.
Print version record.
The first book to collect and synthesize cutting-edge research findings on the treatment of gynecological malignancies into one easy-to-use reference, Clinical Trials in Ovarian Cancer provides physicians with an invaluable resource. Gynecologic oncologist Christine S. Walsh systematically outlines each of the seminal Phase III trials that have shaped the treatment of ovarian cancers, detailing the rationale for the trial, the patient population studied, treatment delivery methods, efficacy, toxicity, and trial conclusions.
This work is licensed under a Creative Commons license
https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode
In English.
JSTOR Books at JSTOR Open Access
There are no comments on this title.